Fathom Therapeutics is a drug design company that uses physics-based simulations and AI to model protein motion and interactions at atomic resolution. Its Microcosmos platform simulates protein dynamics, producing the data needed to design small molecules with differentiated therapeutic effects and reduced off-target risk. The company has an active internal pipeline, multiple discovery partnerships, and has advanced its lead program into animal efficacy studies. Fathom was founded by the team behind the Anton supercomputer and the most widely used software for predicting protein-drug binding. The company is headquartered in New York, with a second office in Boston.

Key Contact

Funding Events

Date	Amount	Type	Investors	Valuation
04/27/26	$47,000,000	Series A	Alexandria Venture Investments Chemistry Empire State Development's NY Ventures Sutter Hill Ventures	undisclosed